EDIT — Editas Medicine Balance Sheet
0.000.00%
- $246.98m
- $140.40m
- $32.31m
Annual balance sheet for Editas Medicine, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 402 | 500 | 344 | 323 | 270 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 6.05 | 0.267 | 5.14 | 10.2 | 16.3 |
| Prepaid Expenses | |||||
| Total Current Assets | 419 | 507 | 357 | 341 | 289 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 39.1 | 43.3 | 59.2 | 45.7 | 47.1 |
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 573 | 677 | 514 | 499 | 342 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 58.2 | 46.9 | 60.1 | 63.2 | 77.2 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 179 | 124 | 154 | 150 | 207 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 394 | 554 | 361 | 349 | 134 |
| Total Liabilities & Shareholders' Equity | 573 | 677 | 514 | 499 | 342 |
| Total Common Shares Outstanding |